All News

Network Meta-Analysis of JAK and TNF Inhib in 19 AS studies (3,654pts) showed best results with TNFi (golimumab and infliximab) but JAKs also appear to be effective option. #ACR20 Abstr#1357 #UTSW @AdelaCastro222 https://t.co/HnnPD6eXW5 https://t.co/Li30kkp3P1

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow’s expanded coverage of the annual #ACR2020 meeting is sponsored in part by @bmsnews, @HorizonNews, @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

axSpA patients have higher rates of c-section,  pre-eclampsia, IUGR and fetal complications vs normal population. Findings from a meta-analysis/systematic review #ABS1323 #ACR20 @RheumNow https://t.co/Ya9r0td7Ev https://t.co/miNURP6bOK

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Distinct gut microbiome in Ankylosing Spondylitis and AS-IBD patients compared with IBD and healthy controls. 1⃣Different alpha and beta-diversity in AS pts vs. IBD 2⃣TNFi use ➡️differentiation microbiome in IBD pts @RheumNow #ACR20 Abs#1310 https://t.co/AGZbJZ9jtR
Robert B Chao, MD doctorRBC ( View Tweet)
Both fat mass and fat free mass have an impact on the response to bDMARDs after 6 months of treatment in AS pts. No tx response changes w/ skeletal muscle mass, visceral fat as well as water components. #ABS1376 #ACR20 @RheumNow https://t.co/oIdE8qvJPp https://t.co/wlXFf8esey

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
In patients with Crohn's disease (CD), the presence of HLA-B27 and higher clinical activity of CD were associated with presence of SpA. SpA was present in 21% of early CD patients @RheumNow #ACR20 Abstr#1308

Dr. Antoni Chan synovialjoints ( View Tweet)

#ABS1303 shows ASAS modification of Berlin algorithm showed optimal balance between sensitivity and specificity and represented the preferred referral strategy for patients presenting w/ undiagnosed back pain & extra-articular features. #ACR20 @RheumNow https://t.co/10VdKC3E75 https://t.co/RgC7K3V8TB

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
For all your nr-axSpA fanatics, there's a fantastic poster on certolizumab response in nr-axSpA stratified by MRI and CRP status #ACR20 @steverheum_hall https://t.co/WI1vdMItUO https://t.co/JnvAyyClDu

Links:

Dr Philip Robinson philipcrobinson ( View Tweet)
@RheumNow #acr20 abs1306 CBP highly prevalent in anterior uveitis. 53%of uveitis pts complain of CBP. 23% eventually diagnosed/meet Dx criteria for AxPsA. 87%had already had CBP w/ previous episodes of uveitis. Men more likely to be clinically diagnosed ( 33%M vs13%F). https://t.co/2y0NxJOFRp
Olga Petryna DrPetryna ( View Tweet)
So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Ultrasound to assess synovial-entheses junction correlated with clinical findings Abs#0311 Do you use MSK US in your clinic? @RheumNow #ACR20

Robert B Chao, MD doctorRBC ( View Tweet)

@RheumNow #acr20 abs0876 gender differences AS and nrSpA from 3 RCT IXE trials: F more likely to be older, have more nocturnal BP, peripheral pain&fatigue. M have higher CRP & +HLAB27. Ant uveitis > in M w/AS (23.8% vs. 17.9%) but > common in F w/ nr-axSpA (15.2% vs. 7.1%). https://t.co/HZa7AfWbBh

Olga Petryna DrPetryna ( View Tweet)
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow + its Faculty.

Dr. John Cush RheumNow ( View Tweet)

Are SpA response differences part of disease subsets or drug pharmacodynamics or both or neither? Data from COASTW & MEASURE2 @RheumNow #ACR2020 @CRASCRRheum https://t.co/GsFjZuZRvI

Links:

Janet Pope Janetbirdope ( View Tweet)

Dr. Jonathan Kay with changes in ICD coding from ICD-9 to ICD-10. And we just got an ICD code for nr-axSpA! It's M46.80 https://t.co/JAlF4ERoHr #ACR20 https://t.co/lmElQVtv35

Links:

Rheum Cat rheum_cat ( View Tweet)
Dr. M. Dubreuil shares a beautiful slide describing the asynchrony between the goal and the reality in the classification of axSpA. Do you think it’s time to change our nomenclature and classification criteria? #ACR20 @RheumNow https://t.co/YJcvLKnyFy
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. J. Kay reviews ICD11 classification codes for medical claims for diagnosing SpA which reviews ASAS criteria. This likely won’t be adopted in the US for several years. #ACR20 ⁦@RheumNow⁩ https://t.co/oDhs1EHSTP
Dr. Rachel Tate uptoTate ( View Tweet)
Do you know Walter Bauer, MD #ACR20? Well, I didn't either! Dr. M. Weinblatt taught me that Dr. Bauer was an important US rheumatologist who did NOT believe AS was a separate disease entity from RA! It wasn't until his death that the college recognized both separately! @RheumNow

Dr. Rachel Tate uptoTate ( View Tweet)

Listen to part I of our #ACR20 Day 1 recap. Listen through the link below or find us on Apple podcasts. https://t.co/W6EMQiF9Rf https://t.co/R1ieCFnIxz

Links:

Dr. John Cush RheumNow ( View Tweet)

Gender differences in Axial Spondyloarthritis patients Pooled data from 3 Ixekizumab studies Women: 1⃣older at disease onset (30 vs. 26) 2⃣Longer symptom duration (17.8 yrs vs. 16.7 yrs) 3⃣More peripheral joint pain and lower HLA-B27 @RheumNow #ACR20 Abs#0876 https://t.co/qGHXApi0Ko

Robert B Chao, MD doctorRBC ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×